Bionik Laboratories Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bionik Laboratories Corp. generated cash of -$3,387,314, which is more than the previous year. Cash used in financing activities reached the amount of $2,050,000 last year. Net change in cash is therefore -$1,563,994.
Cash Flow
| 2013 | -14.60K | 0 | 14.08K |
|---|---|---|---|
| 2014 | -13.20K | -109 | 12.02K |
| 2016 | -4.74M | -547.92K | 4.55M |
| 2017 | -6.99M | -170.79K | 2.32M |
| 2018 | -7.71M | -21.56K | 7.69M |
| 2019 | -9.23M | -101.77K | 9.27M |
| 2020 | -9.06M | -159.64K | 11.04M |
| 2021 | -4.62M | 0 | 2.96M |
| 2022 | -4.14M | -12.5K | 5.55M |
| 2023 | -3.38M | -223.69K | 2.05M |
BNKL Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.99M | 608.34K | 2.26M | 446.77K | 507.31K | 543.65K | 5.38M | 6.12M | 4.42K | 4.94K |
Operating activities | ||||||||||
Net income | -4.94M | -10.40M | -13.62M | -25.01M | -10.55M | -14.62M | -3.93M | 1.03M | -29.52K | -13.10K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 63.16K | 102.62K | 189.73K | 380.64K | 348.20K | 412.93K | 629.94K | 63.45K | 34 | 0 |
Stock-based compensation expense | 376.50K | 438.16K | 819.21K | 1.78M | 1.34M | 1.54M | 844.16K | 1.49M | 112 | 0 |
| Deferred income tax benefit | 376.50K | 438.16K | 819.21K | 1.78M | 1.34M | 1.54M | 844.16K | 1.49M | 112 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -178.24K | 177.06K | 395.05K | 508.72K | -1.29M | 190.86K | -377.41K | 0 | 0 | 0 |
Inventories | 78.37K | -543.95K | 332.45K | -653.78K | -168.23K | -9.19K | -39.37K | 0 | 0 | 0 |
Accounts payable | 262.23K | -148.96K | -407.87K | -291.75K | 424.17K | -60.09K | -332.01K | 112.12K | 16.32K | -1.5K |
Cash generated by operating activities | -3.38M | -4.14M | -4.62M | -9.06M | -9.23M | -7.71M | -6.99M | -4.74M | -13.20K | -14.60K |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -8.69K | -12.5K | 0 | -159.64K | -101.77K | -21.56K | -170.79K | -42.86K | -109 | 0 |
Acquisitions Net | -215K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -223.69K | -12.5K | 0 | -159.64K | -101.77K | -21.56K | -170.79K | -547.92K | -109 | 0 |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 58.36K | 4.55M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 2.04M | 5.55M | -2.96M | -523.83K | 9.27M | -811.55K | 2M | 0 | 0 | 0 |
Cash used in financing activities | 2.05M | 5.55M | 2.96M | 11.04M | 9.27M | 7.69M | 2.32M | 4.55M | 12.02K | 14.08K |
Net Change In Cash | -1.56M | 1.38M | -1.66M | 1.82M | -60.53K | -36.33K | -4.83M | -743.35K | -1.18K | -527 |
Cash at end of period | 427.38K | 1.99M | 608.34K | 2.26M | 446.77K | 507.31K | 543.65K | 5.38M | 3.24K | 4.42K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |